Vasundhara Rasayans

Vasundhara Rasayans Receivables

The Accounts Receivable of Vasundhara Rasayans (538634.BO) as of Oct 30, 2026 is 41.54 M INR. In the previous year, Accounts Receivable was 62.24 M INR — a change of -33.26% (lower).

Receivables

41.54 MINR

YoY

-33.26%

Last updated:

Accounts Receivable of Vasundhara Rasayans is 2025 41.54 M INR. Accounts Receivable of Vasundhara Rasayans was 2024 62.24 M INR. It decreases by -33.26% lower compared to the previous year.

The Vasundhara Rasayans Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2020
62.26 M INR
Jan 1, 2021
61.70 M INR
Jan 1, 2022
73.35 M INR
Jan 1, 2023
80.51 M INR
Jan 1, 2024
62.24 M INR
Jan 1, 2025
41.54 M INR
The Vasundhara Rasayans Receivables history
YEARReceivablesYoY
41.54 MINR-33.26%
62.24 MINR-22.69%
80.51 MINR+9.75%
73.35 MINR+18.89%
61.70 MINR-0.90%
62.26 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vasundhara Rasayans Stock analysis

What does Vasundhara Rasayans do? Vasundhara Rasayans Ltd manufactures and exports active pharmaceutical products for antacid formulations, including Aluminum Hydroxide Gel, Magnesium Hydroxide, Magaldrate, Magnesium Trisilicate, Magnesium Silicate, and Aluminum Phosphate. The company produces these products in paste, powder, and micronized grade powder forms for liquid antacid formulations. It also operates an API intermediate plant with a specialized Friedel Craft reaction facility for organic products. The firm offers Aluminum Hydroxide Gel Low Heavy Lead Content for Lake Color applications and provides Aluminum Hydroxide Amorphous, Aluminum Sulphate, and Poly Aluminum Chloride for water treatment and Aluminum Salts applications. The company's primary customers are pharmaceutical manufacturers requiring antacid therapeutic category Active Pharma Ingredients (API). These manufacturers use Vasundhara Rasayans' products to formulate liquid antacid medications. The firm's API intermediate plant supports the production of organic compounds through its Friedel Craft reaction facility, enhancing its capability to serve the pharmaceutical industry. Vasundhara Rasayans' product range caters to both antacid formulations and specialized applications in water treatment and aluminum salts. Vasundhara Rasayans Ltd generates revenue through the sale of its antacid API products to pharmaceutical companies. The company's manufacturing and export activities focus on delivering high-quality Active Pharma Ingredients for antacid formulations. Its product offerings include specialized variants like Aluminum Hydroxide Gel Low Heavy Lead Content, which targets specific market needs in the pharmaceutical sector. The firm's operations are centered on producing and exporting these pharmaceutical ingredients to meet global demand. Vasundhara Rasayans is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vasundhara Rasayans stock

Accounts Receivable of Vasundhara Rasayans is 41.54 M INR in 2025.

Accounts Receivable of Vasundhara Rasayans changed from 62.24 M INR to 41.54 M INR, representing a -33.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Vasundhara Rasayans since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Vasundhara Rasayans historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Vasundhara Rasayans

All Key Metrics — Vasundhara Rasayans